Literature DB >> 25547683

Coronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice.

Zhangsheng Yang1, Jun Du, Gang Chen, Jie Zhao, Xuanming Yang, Lishan Su, Genhong Cheng, Hong Tang.   

Abstract

It remains challenging to develop animal models of lung infection and severe pneumonia by severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome cornavirus (MERS-CoV) without high level of containment. This inevitably hinders understanding of virushost interaction and development of appropriate countermeasures. Here we report that intranasal inoculation of sublethal doses of murine coronavirus mouse hepatitis virus A-59 (MHV-A59), a hepatic and neuronal tropic coronavirus, can induce acute pneumonia and severe lung injuries in C57BL/6 mice. Inflammatory leukocyte infiltrations, hemorrhages and fibrosis of alveolar walls can be observed 2-11 days after MHV-A59 infection. This pathological manifestation is associated with dramatical elevation of tissue IP-10 and IFN-γ and moderate increase of TNF-α and IL-1β, but inability of anti-viral type I interferon response. These results suggest that intranasal infection of MHV-A59 would serve as a surrogate mouse model of acute respiratory distress syndrome by SARS-CoV and MERS-CoV infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547683      PMCID: PMC7090691          DOI: 10.1007/s12250-014-3530-y

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  61 in total

Review 1.  The role of IFN-gamma in immune responses to viral infections of the central nervous system.

Authors:  David A Chesler; Carol Shoshkes Reiss
Journal:  Cytokine Growth Factor Rev       Date:  2002-12       Impact factor: 7.638

2.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

3.  Mice lacking IL-12 develop polarized Th1 cells during viral infection.

Authors:  V E Schijns; B L Haagmans; C M Wierda; B Kruithof; I A Heijnen; G Alber; M C Horzinek
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

4.  CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10.

Authors:  W E Biddison; W W Cruikshank; D M Center; C M Pelfrey; D D Taub; R V Turner
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

5.  The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation.

Authors:  E Lavi; D H Gilden; M K Highkin; S R Weiss
Journal:  Lab Anim Sci       Date:  1986-04

6.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome.

Authors:  Yong Jiang; Jun Xu; Chengzhi Zhou; Zhenguo Wu; Shuqing Zhong; Jinghua Liu; Wei Luo; Tao Chen; Qinghe Qin; Peng Deng
Journal:  Am J Respir Crit Care Med       Date:  2005-01-18       Impact factor: 21.405

7.  Genetic determinants of mouse hepatitis virus strain 1 pneumovirulence.

Authors:  Julian L Leibowitz; Rajiv Srinivasa; Shawn T Williamson; Ming Ming Chua; Mingfeng Liu; Samantha Wu; Hyojeung Kang; Xue-Zhong Ma; Jianhua Zhang; Itay Shalev; Robert Smith; Melville J Phillips; Gary A Levy; Susan R Weiss
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

8.  Experimental demyelination produced by the A59 strain of mouse hepatitis virus.

Authors:  E Lavi; D H Gilden; Z Wroblewska; L B Rorke; S R Weiss
Journal:  Neurology       Date:  1984-05       Impact factor: 9.910

Review 9.  The molecular cell biology of interferon-gamma and its receptor.

Authors:  M A Farrar; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

10.  Adaptive immune cells temper initial innate responses.

Authors:  Kwang Dong Kim; Jie Zhao; Sogyong Auh; Xuanming Yang; Peishuang Du; Hong Tang; Yang-Xin Fu
Journal:  Nat Med       Date:  2007-09-23       Impact factor: 53.440

View more
  20 in total

Review 1.  Overview of Coronaviruses in Veterinary Medicine.

Authors:  Susan R Compton
Journal:  Comp Med       Date:  2021-08-19       Impact factor: 0.982

2.  Distinct Roles of Type I and Type III Interferons during a Native Murine β Coronavirus Lung Infection.

Authors:  Lokesh Sharma; Xiaohua Peng; Hua Qing; Brandon K Hilliard; Jooyoung Kim; Anush Swaminathan; Justin Tian; Kavita Israni-Winger; Cuiling Zhang; Victoria Habet; Lin Wang; Gayatri Gupta; Xuefei Tian; Yina Ma; Hyeon-Jun Shin; Sang-Hun Kim; Min-Jong Kang; Shuta Ishibe; Lawrence H Young; Sergei Kotenko; Susan Compton; Craig B Wilen; Andrew Wang; Charles S Dela Cruz
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

3.  An assessment of vaping-induced inflammation and toxicity: A feasibility study using a 2-stage zebrafish and mouse platform.

Authors:  Rob U Onyenwoke; TinChung Leung; Xiaoyan Huang; De'Jana Parker; Jeffrey G Shipman; Shatha K Alhadyan; Vijay Sivaraman
Journal:  Food Chem Toxicol       Date:  2022-03-19       Impact factor: 5.572

4.  Critical care medicine for emerging Middle East respiratory syndrome: Which point to be considered?

Authors:  Viroj Wiwanitkit
Journal:  Indian J Crit Care Med       Date:  2015-09

5.  The nucleocapsid proteins of mouse hepatitis virus and severe acute respiratory syndrome coronavirus share the same IFN-β antagonizing mechanism: attenuation of PACT-mediated RIG-I/ MDA5 activation.

Authors:  Zhen Ding; Liurong Fang; Shuangling Yuan; Ling Zhao; Xunlei Wang; Siwen Long; Mohan Wang; Dang Wang; Mohamed Frahat Foda; Shaobo Xiao
Journal:  Oncotarget       Date:  2017-07-25

6.  Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19.

Authors:  Qingqin Tan; Lingjie He; Xiaojun Meng; Wei Wang; Hudan Pan; Weiguo Yin; Tianchuan Zhu; Xi Huang; Hong Shan
Journal:  J Nanobiotechnology       Date:  2021-06-10       Impact factor: 10.435

7.  Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment.

Authors:  Zhaoyan Zhao; Yuchen Xiao; Lingqing Xu; Ye Liu; Guanmin Jiang; Wei Wang; Bin Li; Tianchuan Zhu; Qingqin Tan; Lantian Tang; Haibo Zhou; Xi Huang; Hong Shan
Journal:  ACS Appl Mater Interfaces       Date:  2021-04-30       Impact factor: 9.229

8.  Vaping Exacerbates Coronavirus-Related Pulmonary Infection in a Murine Model.

Authors:  Vijay Sivaraman; De'Jana Parker; Rui Zhang; Myles M Jones; Rob U Onyenwoke
Journal:  Front Physiol       Date:  2021-05-10       Impact factor: 4.566

9.  Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice.

Authors:  Seungjin Ryu; Irina Shchukina; Yun-Hee Youm; Hua Qing; Brandon Hilliard; Tamara Dlugos; Xinbo Zhang; Yuki Yasumoto; Carmen J Booth; Carlos Fernández-Hernando; Yajaira Suárez; Kamal Khanna; Tamas L Horvath; Marcelo O Dietrich; Maxim Artyomov; Andrew Wang; Vishwa Deep Dixit
Journal:  Elife       Date:  2021-06-21       Impact factor: 8.140

Review 10.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

Authors:  Robert W Körner; Mohamed Majjouti; Miguel A Alejandre Alcazar; Esther Mahabir
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.